Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

Gottlieb: Delta wave could burn out by Thanksgiving

By Brian Buntz | September 27, 2021

Dr. Scott Gottlieb. FDA file photo from 2017.

Dr. Scott Gottlieb. [FDA file photo from 2017]

Pfizer board member Dr. Scott Gottlieb has predicted that the COVID-19 Delta surge could mark a high-water mark of the pandemic.

“This may be the last major wave of infection,” said Gottlieb, who served as the FDA commissioner from 2017 to 2019.

In an interview with CNN, Gottlieb predicted that the pandemic in the U.S. would transition from pandemic to endemic phase in the relatively near future.

Gottlieb did, however, suggest that the U.S. would see ongoing pockets of high caseloads as the Delta wave shifts from affecting predominantly Southern states to other regions. For example, Montana, Wyoming and West Virginia are current hot spots of infection.

Gottlieb also acknowledged that a new variant could potentially emerge that resists natural or vaccinated immunity.

The Delta wave, however, will likely dissipate by Thanksgiving in Gottlieb’s estimation.

COVID-19 cases have dipped 18% in the U.S. over the past two weeks.

CDC infection rates

The current wave of infections is the second-largest to date. Image from CDC.

“The virus isn’t going away, but prevalence levels will decline to a level that feels more manageable,” Gottlieb said.

The increase in respiratory cold and flu infections in the winter months will heighten demand for COVID-19 testing, he added, pointing out that the flu season could be mild as it was in 2020.

The natural tendency for people to spend more time indoors in the winter months could also exacerbate COVID-19 infection rates.

Nevertheless, Gottlieb surmised that approximately 80% of the U.S. public likely has some degree of immunity against the novel coronavirus, whether from vaccines or natural infection. That level could increase to 90% by the winter, he predicted.

Vaccination could be available to more children in the coming months.

Pfizer will likely submit data to FDA for vaccines in children under 12 this week.

About The Author

Brian Buntz

The pharma and biotech editor of WTWH Media, Brian is a veteran journalist with more than 15 years of experience covering an array of life science topics, including clinical trials, drug discovery and development and medical devices. Before coming to WTWH, he served as content director focused on connected devices at Informa. In addition, Brian covered the medical device sector for 10 years at UBM. At Qmed, he overhauled the brand’s news coverage and helped to grow the site’s traffic volume dramatically. He had previously held managing editor roles on two of the company’s medical device technology publications. Connect with him on LinkedIn or email at bbuntz@wtwhmedia.com.

Tell Us What You Think! Cancel reply

Related Articles Read More >

institut pasteur dakar IPD African Union vaccine investment
African Union vaccine initiative receives $45M
Sen-Jam Pharma, KVK-Tech partnering for manufacturing and formulation for anti-inflammatory injectables
This image shows the Moderna logo.
Moderna resizes its manufacturing footprint for a post-pandemic era
This is the logo of Pfizer.
Pfizer to close Durham and Morrisville, North Carolina facilities amid major restructuring effort
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE